← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2003Last known activity
Mar 18, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT05249816Overall official - principal investigatorPhase 3Mar 18, 2022
- NCT05848505Lead sponsorN/AFeb 25, 2022
- NCT05848505Sponsor investigatorN/AFeb 25, 2022
- NCT04917523Overall official - principal investigatorPhase 3Jun 6, 2021
- NCT00151905Overall official - principal investigatorPhase 2/Phase 3Nov 1, 2003
- NCT00151905Lead sponsorPhase 2/Phase 3Nov 1, 2003
Details
- Last known activity
- Mar 18, 2022